ADAR1 CAPITAL MANAGEMENT, LLC purchased 1.2% of their position (10.90K shares) of INMED PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $14.5K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 10/8/2026ACC: 0001940272-26-000023
10% Owner
Since May 2026
+10.90K
Net shares
Net buyer
$14.5K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
10.90K acquired
Non-Derivative Transactions3
Common Shares
Indirect
Shares
+5.60K
Price / share
$1.33
Trade value
$7.44K
% of position
0.6%
10/6/2026
935.02K→940.62K
Common Shares
Indirect
Shares
+3.05K
Price / share
$1.33
Trade value
$4.05K
% of position
0.3%
10/7/2026
940.62K→943.67K
Common Shares
Indirect
Shares
+2.26K
Price / share
$1.33
Trade value
$3K
% of position
0.2%
10/8/2026
943.67K→945.92K
Total
Net shares
+10.90K
Net value
$14.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 10/6/2026 | P · Purchase | +5.60K | $1.33 | $7.44K | 0.6% | 935.02K | 940.62K |
| Common Shares Indirect | 10/7/2026 | P · Purchase | +3.05K | $1.33 | $4.05K | 0.3% | 940.62K | 943.67K |
| Common Shares Indirect | 10/8/2026 | P · Purchase | +2.26K | $1.33 | $3K | 0.2% | 943.67K | 945.92K |
| Total | +10.90K | $14.48K | ||||||
Derivative Transactions0
No derivative transactions reported